Press Release | Fri Mar 6, 2009 6:34pm EST

FDA Appeal Decision Indicates that Genasense® Approval in Chronic Lymphocytic Leukemia Will Require Additional Confirmatory Trial

* Reuters is not responsible for the content in this press release.